Alnylam Pharmaceuticals, Inc. (ALNY)
336.23
-3.14
(-0.93%)
USD |
NASDAQ |
Feb 20, 16:00
337.00
+0.77
(+0.23%)
After-Hours: 20:00
Alnylam Pharmaceuticals EPS Basic from Accounting Change (Quarterly)
EPS Basic from Accounting Change (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Basic from Accounting Change (Quarterly) Benchmarks
| Insmed, Inc. | -- |
| Biogen, Inc. | -- |
| Pfizer Inc. | -- |
| Eli Lilly & Co. | -- |
| AbbVie, Inc. | -- |